In vitro studies demonstrated that the expression of MUC1 is involved in the invasion and resistance to genotoxic anticancer reagents suggesting that it is closely associated with poor prognosis of patients with breast cancer [7]. This evidence concerns the gene MUC1 and breast cancer.